Gempower 200mg Injection

About

Gempower 200mg Injection contains Gemcitabine, an antimetabolite chemotherapy agent that interferes with DNA synthesis and repair, leading to cell death. It is a prodrug that is intracellularly metabolized to active diphosphate and triphosphate nucleosides. These active metabolites inhibit DNA polymerase and ribonucleotide reductase, thereby disrupting DNA replication and repair mechanisms in rapidly dividing cancer cells. Gemcitabine is widely used in the treatment of various solid tumors, including pancreatic, non-small cell lung, breast, and ovarian cancers, often in combination with other chemotherapeutic agents. Its mechanism of action makes it effective against a broad spectrum of malignancies, contributing to improved patient outcomes and disease control in advanced stages of cancer.

Uses

• Pancreatic cancer.
• Non-small cell lung cancer.
• Breast cancer.
• Ovarian cancer.

Directions For Use

Administer intravenously under the supervision of a qualified healthcare professional.

Benefits

• Effective against various solid tumors.
• Can improve survival in advanced cancers.
• Often used in combination regimens.
• May reduce tumor size and symptoms.
• Relatively well-tolerated compared to some other chemotherapies.
• Established efficacy in multiple cancer types.

Side Effects

• Myelosuppression (low blood counts)
• Nausea
• Vomiting
• Fatigue
• Flu-like symptoms
• Rash
• Hair loss (alopecia)
• Diarrhea
• Constipation
• Liver enzyme elevation
• Kidney dysfunction
• Peripheral edema

Safety Measures

• Alcohol - Avoid or limit alcohol due to potential for increased liver toxicity and gastrointestinal irritation.
• Pregnancy - Contraindicated; can cause severe fetal harm. Effective contraception is required.
• Breastfeeding - Not recommended; discontinue breastfeeding during treatment due to potential harm to the infant.
• Liver - Use with caution in patients with hepatic impairment; monitor liver function closely. Dose adjustment may be needed.
• Kidney - Use with caution in patients with renal impairment; monitor renal function closely. Dose adjustment may be needed.
• Lung - Can cause severe pulmonary toxicity, including interstitial pneumonitis and ARDS; monitor for respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.